Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Rigel PharmaceuticalsDynavax TechnologiesUrovant SciencesXeris PharmaceuticalsProQR Therapeutics
SymbolNASDAQ:RIGLNASDAQ:DVAXNASDAQ:UROVNASDAQ:XERSNASDAQ:PRQR
Price Information
Current Price$1.64$4.08$9.38$9.01$6.45
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$7.33$19.00$24.00$22.50$30.40
% Upside from Price Target348.52% upside365.69% upside155.86% upside149.72% upside371.32% upside
Trade Information
Market Cap$268.17 million$276.26 million$287.02 million$242.89 million$263.95 million
Beta1.350.46N/A-0.440.15
Average Volume1,780,9201,145,85645,377121,206255,697
Sales & Book Value
Annual Revenue$44.51 million$8.20 millionN/A$2.46 millionN/A
Price / Sales6.1632.42N/A98.85N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.66 per share$1.01 per share$2.47 per share$3.61 per share$2.83 per share
Price / Book2.484.04N/A2.50N/A
Profitability
Net Income$-70,480,000.00$-158,900,000.00$-111,350,000.00$-60,080,000.00$-43,570,000.00
EPS($0.44)($2.55)($4.43)($4.99)($1.29)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-89.34%-781.10%N/A-4,876.50%N/A
Return on Equity (ROE)-60.72%-304.71%-199.22%-107.65%-50.97%
Return on Assets (ROA)-39.74%-64.45%-142.39%-68.67%-41.92%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.29%19.95%0.29%0.39%0.16%
Current Ratio4.39%4.30%6.20%6.00%9.51%
Quick Ratio4.34%3.47%6.20%6.00%9.51%
Ownership Information
Institutional Ownership Percentage89.79%80.80%24.10%62.44%60.79%
Insider Ownership Percentage4.96%4.90%2.40%7.43%N/A
Miscellaneous
Employees1582491790118
Shares Outstanding167.61 million65.15 million30.34 million26.99 million38.87 million
Next Earnings Date11/5/2019 (Estimated)11/4/2019 (Estimated)11/11/2019 (Estimated)11/6/2019 (Estimated)11/6/2019 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable
 Rigel PharmaceuticalsDynavax TechnologiesUrovant SciencesXeris PharmaceuticalsProQR Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel